logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
23/02/2026
Novo Nordisk (NVO.N) stated that in clinical trials, the effectiveness of the company's Cagrisema did not meet the efficacy standard of Eli Lilly's Tirzepatide.
Latest
6 m ago
Bank of England's Taylor: Expectations weaken in terms of output gap and unemployment.
6 m ago
Qianwen revealed that during the Spring Festival, there were 200 million orders placed with just one sentence.
6 m ago
Bank of England Monetary Policy Committee member Taylor: will sustainably approach the CPI target.
7 m ago
Domino's Pizza reported fourth quarter revenue of $1.54 billion, exceeding the estimated $1.52 billion.
8 m ago
Arcellx's pre-market stock surged more than 76%, as Gilead Sciences will acquire Arcellx at a price of $115 per share.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.